| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orthopedics | 6 | 2020 | 130 | 1.310 |
Why?
|
| Osteochondrodysplasias | 4 | 2021 | 11 | 1.280 |
Why?
|
| Burnout, Professional | 3 | 2020 | 102 | 1.230 |
Why?
|
| Practice Guidelines as Topic | 11 | 2019 | 1050 | 0.940 |
Why?
|
| Colonic Neoplasms | 15 | 2018 | 571 | 0.860 |
Why?
|
| Evidence-Based Medicine | 7 | 2013 | 434 | 0.770 |
Why?
|
| Societies, Medical | 5 | 2020 | 582 | 0.750 |
Why?
|
| Arthritis, Juvenile | 1 | 2021 | 33 | 0.750 |
Why?
|
| Workplace | 1 | 2020 | 30 | 0.710 |
Why?
|
| Orthopedic Surgeons | 1 | 2020 | 14 | 0.710 |
Why?
|
| Pediatrics | 4 | 2019 | 357 | 0.690 |
Why?
|
| Osteoarthritis, Knee | 4 | 2023 | 66 | 0.660 |
Why?
|
| Occupational Health | 1 | 2019 | 36 | 0.640 |
Why?
|
| Self Report | 1 | 2020 | 296 | 0.630 |
Why?
|
| Organizational Policy | 1 | 2019 | 55 | 0.630 |
Why?
|
| Humans | 117 | 2023 | 89613 | 0.610 |
Why?
|
| Empathy | 1 | 2020 | 151 | 0.610 |
Why?
|
| Spectrum Analysis | 10 | 2015 | 119 | 0.610 |
Why?
|
| Colorectal Neoplasms | 8 | 2018 | 979 | 0.600 |
Why?
|
| Hip Dislocation, Congenital | 5 | 2015 | 12 | 0.580 |
Why?
|
| Achondroplasia | 4 | 2018 | 8 | 0.570 |
Why?
|
| Editorial Policies | 1 | 2017 | 34 | 0.560 |
Why?
|
| Physicians | 3 | 2020 | 691 | 0.560 |
Why?
|
| Musculoskeletal Abnormalities | 3 | 2019 | 9 | 0.530 |
Why?
|
| Clavicle | 2 | 2013 | 10 | 0.530 |
Why?
|
| Rectum | 7 | 2018 | 148 | 0.510 |
Why?
|
| Adenoma | 9 | 2015 | 250 | 0.500 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 168 | 0.490 |
Why?
|
| Knee Prosthesis | 2 | 2023 | 32 | 0.480 |
Why?
|
| Videotape Recording | 1 | 2014 | 48 | 0.450 |
Why?
|
| Colonoscopy | 5 | 2022 | 281 | 0.450 |
Why?
|
| Community Health Workers | 1 | 2014 | 33 | 0.440 |
Why?
|
| North America | 3 | 2020 | 184 | 0.430 |
Why?
|
| Gastrointestinal Diseases | 2 | 2011 | 150 | 0.410 |
Why?
|
| Esophagus | 2 | 2013 | 107 | 0.410 |
Why?
|
| Health Promotion | 1 | 2014 | 165 | 0.400 |
Why?
|
| Baroreflex | 1 | 2011 | 8 | 0.400 |
Why?
|
| Cerebral Palsy | 4 | 2000 | 97 | 0.390 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2011 | 2 | 0.390 |
Why?
|
| Exostoses | 1 | 2011 | 3 | 0.390 |
Why?
|
| Fractures, Bone | 1 | 2013 | 133 | 0.390 |
Why?
|
| Blood Vessels | 1 | 2011 | 94 | 0.380 |
Why?
|
| Colon | 7 | 2012 | 519 | 0.380 |
Why?
|
| Health Services | 1 | 2011 | 57 | 0.380 |
Why?
|
| Intestinal Mucosa | 10 | 2015 | 805 | 0.380 |
Why?
|
| Femur | 3 | 2021 | 112 | 0.370 |
Why?
|
| Dental Care for Children | 1 | 2010 | 1 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2014 | 449 | 0.360 |
Why?
|
| Quality of Health Care | 2 | 2020 | 386 | 0.360 |
Why?
|
| Abnormalities, Multiple | 4 | 2003 | 234 | 0.360 |
Why?
|
| Checklist | 2 | 2021 | 61 | 0.340 |
Why?
|
| Pancreatic Neoplasms | 5 | 2015 | 682 | 0.340 |
Why?
|
| Male | 53 | 2020 | 42488 | 0.340 |
Why?
|
| Child | 27 | 2021 | 7216 | 0.330 |
Why?
|
| Hospitals | 1 | 2011 | 303 | 0.320 |
Why?
|
| Esophageal Spasm, Diffuse | 1 | 2008 | 2 | 0.320 |
Why?
|
| Barium Sulfate | 1 | 2008 | 43 | 0.310 |
Why?
|
| Exercise | 1 | 2011 | 326 | 0.310 |
Why?
|
| Bone Diseases, Developmental | 4 | 1996 | 11 | 0.300 |
Why?
|
| Orthopedic Procedures | 4 | 2015 | 129 | 0.300 |
Why?
|
| Spinal Fusion | 3 | 2020 | 86 | 0.300 |
Why?
|
| Female | 48 | 2022 | 46401 | 0.290 |
Why?
|
| Disease Management | 4 | 2019 | 326 | 0.290 |
Why?
|
| Down Syndrome | 4 | 1993 | 55 | 0.280 |
Why?
|
| Radiography | 17 | 2011 | 806 | 0.280 |
Why?
|
| Fracture Fixation | 3 | 2012 | 31 | 0.280 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 2646 | 0.260 |
Why?
|
| Foramen Magnum | 2 | 2016 | 4 | 0.260 |
Why?
|
| Humeral Fractures | 2 | 2019 | 18 | 0.260 |
Why?
|
| Hypertension | 1 | 2011 | 747 | 0.260 |
Why?
|
| Growth Disorders | 2 | 2003 | 63 | 0.260 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 435 | 0.240 |
Why?
|
| Infant | 15 | 2021 | 3176 | 0.240 |
Why?
|
| Precancerous Conditions | 4 | 2015 | 200 | 0.240 |
Why?
|
| Hip Joint | 4 | 1994 | 54 | 0.240 |
Why?
|
| Body Height | 2 | 2018 | 100 | 0.240 |
Why?
|
| Biomarkers, Tumor | 7 | 2018 | 1541 | 0.240 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2004 | 72 | 0.240 |
Why?
|
| Synovial Membrane | 2 | 2018 | 28 | 0.230 |
Why?
|
| Knee Joint | 3 | 2023 | 165 | 0.230 |
Why?
|
| Range of Motion, Articular | 3 | 2003 | 156 | 0.230 |
Why?
|
| Cholangiocarcinoma | 1 | 2004 | 76 | 0.220 |
Why?
|
| Arthroscopy | 7 | 2023 | 93 | 0.220 |
Why?
|
| Bile Duct Neoplasms | 1 | 2004 | 90 | 0.220 |
Why?
|
| Duodenum | 3 | 2015 | 105 | 0.210 |
Why?
|
| Child, Preschool | 12 | 2021 | 3756 | 0.210 |
Why?
|
| Mass Screening | 2 | 2008 | 645 | 0.210 |
Why?
|
| Colitis, Microscopic | 1 | 2022 | 6 | 0.210 |
Why?
|
| Early Detection of Cancer | 5 | 2015 | 419 | 0.210 |
Why?
|
| Prosthesis-Related Infections | 2 | 2013 | 61 | 0.210 |
Why?
|
| Joint Instability | 3 | 2003 | 82 | 0.210 |
Why?
|
| Osteochondritis Dissecans | 2 | 2012 | 5 | 0.200 |
Why?
|
| Adult | 23 | 2020 | 26704 | 0.200 |
Why?
|
| Middle Aged | 25 | 2020 | 26012 | 0.200 |
Why?
|
| Adolescent | 17 | 2021 | 9305 | 0.190 |
Why?
|
| Colonic Polyps | 4 | 2011 | 132 | 0.190 |
Why?
|
| Sigmoidoscopy | 3 | 2010 | 36 | 0.190 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2023 | 114 | 0.190 |
Why?
|
| Scattering, Radiation | 6 | 2013 | 116 | 0.190 |
Why?
|
| Toes | 1 | 2021 | 14 | 0.190 |
Why?
|
| Fractures, Compression | 2 | 2011 | 17 | 0.190 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2018 | 23 | 0.190 |
Why?
|
| Ankle | 2 | 2000 | 20 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2008 | 2668 | 0.190 |
Why?
|
| Aged | 17 | 2020 | 19158 | 0.190 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 360 | 0.190 |
Why?
|
| Adenocarcinoma | 3 | 2015 | 1185 | 0.190 |
Why?
|
| Sensitivity and Specificity | 9 | 2015 | 2016 | 0.180 |
Why?
|
| Spine | 2 | 2020 | 102 | 0.180 |
Why?
|
| Achilles Tendon | 2 | 2010 | 15 | 0.180 |
Why?
|
| Materials Testing | 2 | 2018 | 93 | 0.180 |
Why?
|
| Spinal Fractures | 2 | 2011 | 81 | 0.180 |
Why?
|
| Functional Neuroimaging | 1 | 2020 | 31 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2022 | 243 | 0.180 |
Why?
|
| Radius Fractures | 2 | 2011 | 33 | 0.180 |
Why?
|
| Neuromuscular Agents | 1 | 2000 | 27 | 0.170 |
Why?
|
| Gait | 1 | 2000 | 81 | 0.170 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2000 | 50 | 0.170 |
Why?
|
| Patient Preference | 1 | 2020 | 110 | 0.170 |
Why?
|
| Aspirin | 2 | 2022 | 160 | 0.160 |
Why?
|
| Anticarcinogenic Agents | 2 | 2018 | 73 | 0.160 |
Why?
|
| Collagen Type II | 1 | 2019 | 14 | 0.160 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 1605 | 0.160 |
Why?
|
| Infant, Newborn | 11 | 2021 | 2488 | 0.160 |
Why?
|
| Foot Deformities, Congenital | 2 | 2000 | 10 | 0.160 |
Why?
|
| Musculoskeletal System | 1 | 1998 | 15 | 0.160 |
Why?
|
| Sutures | 1 | 2018 | 57 | 0.160 |
Why?
|
| Job Satisfaction | 1 | 2019 | 79 | 0.160 |
Why?
|
| Aberrant Crypt Foci | 1 | 2018 | 7 | 0.150 |
Why?
|
| Chondroitinsulfatases | 1 | 2018 | 1 | 0.150 |
Why?
|
| Mucopolysaccharidosis IV | 1 | 2018 | 2 | 0.150 |
Why?
|
| Laxatives | 1 | 2018 | 13 | 0.150 |
Why?
|
| Health Status | 2 | 1998 | 371 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 153 | 0.150 |
Why?
|
| Young Adult | 5 | 2020 | 6368 | 0.150 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 110 | 0.150 |
Why?
|
| Tibia | 3 | 1994 | 78 | 0.150 |
Why?
|
| Desensitization, Immunologic | 1 | 2018 | 37 | 0.150 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2016 | 107 | 0.150 |
Why?
|
| Fiber Optic Technology | 2 | 2015 | 36 | 0.150 |
Why?
|
| Rituximab | 1 | 2018 | 117 | 0.150 |
Why?
|
| Methotrexate | 1 | 2018 | 242 | 0.140 |
Why?
|
| Education, Medical | 1 | 2020 | 243 | 0.140 |
Why?
|
| Biopsy | 4 | 2015 | 1183 | 0.140 |
Why?
|
| Patient Safety | 1 | 2019 | 218 | 0.140 |
Why?
|
| Nerve Net | 1 | 2020 | 374 | 0.140 |
Why?
|
| Platelet-Derived Growth Factor | 5 | 1996 | 66 | 0.130 |
Why?
|
| Risk Factors | 10 | 2022 | 5517 | 0.130 |
Why?
|
| Duodenoscopy | 1 | 2015 | 9 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2023 | 8218 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2017 | 168 | 0.130 |
Why?
|
| United States | 6 | 2021 | 7050 | 0.130 |
Why?
|
| Tomography, Optical Coherence | 2 | 2014 | 136 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 345 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1996 | 306 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 624 | 0.120 |
Why?
|
| ErbB Receptors | 1 | 2018 | 498 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 401 | 0.120 |
Why?
|
| Fatty Acid Synthases | 1 | 2014 | 8 | 0.120 |
Why?
|
| Mutation | 3 | 2018 | 4160 | 0.120 |
Why?
|
| Decision Making | 1 | 2020 | 669 | 0.120 |
Why?
|
| Escherichia | 1 | 1994 | 1 | 0.120 |
Why?
|
| Braces | 3 | 2013 | 13 | 0.120 |
Why?
|
| Foreign-Body Reaction | 1 | 1994 | 11 | 0.120 |
Why?
|
| Wood | 1 | 1994 | 19 | 0.120 |
Why?
|
| Enterobacteriaceae Infections | 1 | 1994 | 24 | 0.110 |
Why?
|
| Cervical Vertebrae | 2 | 1993 | 84 | 0.110 |
Why?
|
| Rats | 8 | 2018 | 4041 | 0.110 |
Why?
|
| Osteomyelitis | 1 | 1994 | 55 | 0.110 |
Why?
|
| Inservice Training | 1 | 2014 | 38 | 0.110 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 6771 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 78 | 0.110 |
Why?
|
| Wounds, Penetrating | 1 | 1994 | 56 | 0.110 |
Why?
|
| Tendon Injuries | 2 | 2010 | 36 | 0.110 |
Why?
|
| American Dental Association | 1 | 2013 | 9 | 0.110 |
Why?
|
| Dental Care | 1 | 2013 | 12 | 0.110 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1994 | 152 | 0.110 |
Why?
|
| Point-of-Care Systems | 2 | 2015 | 145 | 0.110 |
Why?
|
| Oral Surgical Procedures | 1 | 2013 | 19 | 0.110 |
Why?
|
| Dental Implants | 1 | 2013 | 11 | 0.110 |
Why?
|
| Sports | 1 | 1993 | 40 | 0.110 |
Why?
|
| Forearm | 2 | 2011 | 31 | 0.110 |
Why?
|
| Barrett Esophagus | 1 | 2013 | 94 | 0.100 |
Why?
|
| Light | 6 | 2013 | 292 | 0.100 |
Why?
|
| Administrative Personnel | 1 | 2012 | 10 | 0.100 |
Why?
|
| Surgeons | 1 | 2016 | 249 | 0.100 |
Why?
|
| Conflict of Interest | 1 | 2012 | 68 | 0.100 |
Why?
|
| Leg | 2 | 2011 | 140 | 0.100 |
Why?
|
| Lower Body Negative Pressure | 1 | 2011 | 3 | 0.100 |
Why?
|
| Osteoporosis | 2 | 2011 | 124 | 0.100 |
Why?
|
| Cost Allocation | 1 | 2011 | 5 | 0.100 |
Why?
|
| Hyperemia | 1 | 2011 | 19 | 0.100 |
Why?
|
| Pressoreceptors | 1 | 2011 | 12 | 0.100 |
Why?
|
| Bicycling | 1 | 2011 | 13 | 0.100 |
Why?
|
| Prospective Studies | 6 | 2021 | 4309 | 0.100 |
Why?
|
| Nails, Malformed | 1 | 2011 | 3 | 0.100 |
Why?
|
| Nails | 1 | 2011 | 11 | 0.100 |
Why?
|
| Fractures, Spontaneous | 1 | 2011 | 11 | 0.100 |
Why?
|
| Hospital Bed Capacity | 1 | 2011 | 20 | 0.100 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2011 | 13 | 0.100 |
Why?
|
| Vascular Resistance | 1 | 2011 | 103 | 0.100 |
Why?
|
| Vascular Stiffness | 1 | 2011 | 29 | 0.100 |
Why?
|
| Rotator Cuff | 1 | 2012 | 41 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2012 | 64 | 0.100 |
Why?
|
| Shoulder Joint | 2 | 2010 | 92 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2013 | 213 | 0.100 |
Why?
|
| Osteochondroma | 1 | 1991 | 7 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2015 | 1254 | 0.090 |
Why?
|
| Scoliosis | 2 | 1994 | 32 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 224 | 0.090 |
Why?
|
| Uncompensated Care | 1 | 2010 | 2 | 0.090 |
Why?
|
| Dental Clinics | 1 | 2010 | 3 | 0.090 |
Why?
|
| Bone Neoplasms | 3 | 1992 | 322 | 0.090 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 245 | 0.090 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 333 | 0.090 |
Why?
|
| Israel | 1 | 2010 | 57 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 476 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 1991 | 108 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2011 | 135 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2011 | 149 | 0.090 |
Why?
|
| Health Care Costs | 1 | 2012 | 236 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2011 | 72 | 0.090 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2009 | 163 | 0.090 |
Why?
|
| Physical Examination | 4 | 2010 | 149 | 0.090 |
Why?
|
| Microvessels | 1 | 2010 | 69 | 0.090 |
Why?
|
| Diagnostic Equipment | 1 | 2009 | 3 | 0.090 |
Why?
|
| Osteoporotic Fractures | 1 | 2011 | 50 | 0.090 |
Why?
|
| Arthroplasty, Replacement | 1 | 2010 | 37 | 0.090 |
Why?
|
| Brain | 1 | 2020 | 2300 | 0.090 |
Why?
|
| Activities of Daily Living | 3 | 1998 | 205 | 0.090 |
Why?
|
| Femoral Fractures | 1 | 2009 | 27 | 0.080 |
Why?
|
| Syndrome | 3 | 2003 | 449 | 0.080 |
Why?
|
| Carcinogenicity Tests | 1 | 2009 | 5 | 0.080 |
Why?
|
| Electrodiagnosis | 1 | 2009 | 7 | 0.080 |
Why?
|
| Prognosis | 5 | 2015 | 3785 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2011 | 120 | 0.080 |
Why?
|
| Osteoarthritis | 1 | 2010 | 75 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2015 | 2763 | 0.080 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2009 | 17 | 0.080 |
Why?
|
| Poisoning | 2 | 1986 | 42 | 0.080 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2009 | 54 | 0.080 |
Why?
|
| Stroke Volume | 1 | 2011 | 465 | 0.080 |
Why?
|
| Rats, Inbred F344 | 5 | 2007 | 154 | 0.080 |
Why?
|
| Bone Cysts | 1 | 1988 | 8 | 0.080 |
Why?
|
| Scapula | 1 | 1988 | 24 | 0.080 |
Why?
|
| Poverty | 1 | 2010 | 183 | 0.080 |
Why?
|
| Liver Cirrhosis, Biliary | 3 | 1982 | 28 | 0.080 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 1727 | 0.080 |
Why?
|
| Case-Control Studies | 4 | 2015 | 1862 | 0.070 |
Why?
|
| Menisci, Tibial | 2 | 2013 | 26 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 971 | 0.070 |
Why?
|
| Carcinoma | 1 | 2011 | 438 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2011 | 902 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2007 | 88 | 0.070 |
Why?
|
| Joints | 1 | 2007 | 32 | 0.070 |
Why?
|
| Occult Blood | 1 | 2006 | 18 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 82 | 0.070 |
Why?
|
| Age Factors | 5 | 2012 | 1877 | 0.070 |
Why?
|
| Chemoprevention | 2 | 2018 | 92 | 0.070 |
Why?
|
| Critical Care | 1 | 2009 | 384 | 0.070 |
Why?
|
| Azoxymethane | 4 | 2007 | 84 | 0.070 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 153 | 0.070 |
Why?
|
| Dupuytren Contracture | 2 | 1996 | 3 | 0.070 |
Why?
|
| Ectromelia | 1 | 1985 | 4 | 0.060 |
Why?
|
| Veterans | 1 | 2006 | 85 | 0.060 |
Why?
|
| Myositis Ossificans | 1 | 1985 | 3 | 0.060 |
Why?
|
| Endoscopy, Digestive System | 1 | 2006 | 69 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2009 | 837 | 0.060 |
Why?
|
| Artificial Limbs | 1 | 1985 | 21 | 0.060 |
Why?
|
| Equipment Design | 3 | 2015 | 420 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 520 | 0.060 |
Why?
|
| Algorithms | 2 | 2004 | 1903 | 0.060 |
Why?
|
| Atlanto-Axial Joint | 1 | 1984 | 9 | 0.060 |
Why?
|
| Constriction, Pathologic | 2 | 2016 | 219 | 0.060 |
Why?
|
| Homeostasis | 1 | 2007 | 417 | 0.060 |
Why?
|
| Joint Dislocations | 1 | 1984 | 27 | 0.060 |
Why?
|
| Gastric Bypass | 1 | 2006 | 113 | 0.060 |
Why?
|
| beta Catenin | 1 | 2006 | 266 | 0.060 |
Why?
|
| Pilot Projects | 4 | 2009 | 870 | 0.060 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2004 | 68 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 2020 | 2297 | 0.060 |
Why?
|
| Endosonography | 1 | 2004 | 99 | 0.060 |
Why?
|
| Hand | 2 | 2003 | 142 | 0.060 |
Why?
|
| Intellectual Disability | 2 | 2003 | 189 | 0.060 |
Why?
|
| Fibroma | 2 | 1995 | 33 | 0.050 |
Why?
|
| Australia | 1 | 2023 | 101 | 0.050 |
Why?
|
| Contrast Media | 1 | 2008 | 1084 | 0.050 |
Why?
|
| Microcirculation | 3 | 2009 | 104 | 0.050 |
Why?
|
| Cutis Laxa | 1 | 2003 | 4 | 0.050 |
Why?
|
| Hair Diseases | 1 | 2003 | 9 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2003 | 72 | 0.050 |
Why?
|
| Gonadal Dysgenesis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2018 | 1710 | 0.050 |
Why?
|
| Immune Complex Diseases | 1 | 1982 | 19 | 0.050 |
Why?
|
| Endocrine System Diseases | 1 | 2002 | 23 | 0.050 |
Why?
|
| Facial Expression | 1 | 2003 | 51 | 0.050 |
Why?
|
| Microscopy | 2 | 2013 | 87 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2013 | 201 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2002 | 33 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 1982 | 87 | 0.050 |
Why?
|
| Electric Stimulation Therapy | 2 | 2013 | 47 | 0.050 |
Why?
|
| Patient Satisfaction | 2 | 1998 | 460 | 0.050 |
Why?
|
| Animals | 9 | 2018 | 27481 | 0.050 |
Why?
|
| Terminology as Topic | 2 | 2001 | 221 | 0.050 |
Why?
|
| Computers | 1 | 2021 | 111 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 1725 | 0.050 |
Why?
|
| Diarrhea | 1 | 2022 | 178 | 0.050 |
Why?
|
| Immobilization | 2 | 2012 | 21 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1995 | 665 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2003 | 202 | 0.050 |
Why?
|
| Splints | 2 | 2011 | 10 | 0.050 |
Why?
|
| Casts, Surgical | 2 | 2011 | 9 | 0.050 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2001 | 19 | 0.050 |
Why?
|
| Reoperation | 1 | 2023 | 603 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 2384 | 0.050 |
Why?
|
| Absorbable Implants | 1 | 2001 | 35 | 0.050 |
Why?
|
| Rupture | 2 | 2010 | 61 | 0.050 |
Why?
|
| Foreign-Body Migration | 1 | 2001 | 39 | 0.040 |
Why?
|
| Knee Injuries | 1 | 2001 | 54 | 0.040 |
Why?
|
| Weight-Bearing | 2 | 2010 | 67 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2021 | 9127 | 0.040 |
Why?
|
| Bone Transplantation | 2 | 2011 | 67 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2015 | 782 | 0.040 |
Why?
|
| Neuromuscular Blockade | 1 | 2000 | 26 | 0.040 |
Why?
|
| Optics and Photonics | 2 | 2013 | 27 | 0.040 |
Why?
|
| Morbidity | 1 | 2020 | 149 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2001 | 64 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 2003 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2015 | 2304 | 0.040 |
Why?
|
| Phthalic Acids | 1 | 2018 | 4 | 0.040 |
Why?
|
| Polyethylene | 1 | 2018 | 7 | 0.040 |
Why?
|
| Pregnancy | 2 | 2018 | 3038 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2006 | 777 | 0.040 |
Why?
|
| Self-Assessment | 1 | 1998 | 47 | 0.040 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2018 | 2 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 327 | 0.040 |
Why?
|
| Placebo Effect | 1 | 2018 | 30 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2006 | 1663 | 0.040 |
Why?
|
| Inflammation | 2 | 2018 | 975 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2018 | 303 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2018 | 57 | 0.040 |
Why?
|
| Craniofacial Dysostosis | 1 | 1977 | 12 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 1073 | 0.040 |
Why?
|
| Suture Techniques | 1 | 2018 | 144 | 0.040 |
Why?
|
| Calcaneus | 1 | 1977 | 34 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2018 | 205 | 0.040 |
Why?
|
| Incidence | 3 | 2013 | 1598 | 0.040 |
Why?
|
| Fantasy | 1 | 2016 | 2 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2018 | 344 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1996 | 16 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 860 | 0.030 |
Why?
|
| Charcoal | 2 | 1986 | 13 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 258 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2006 | 2878 | 0.030 |
Why?
|
| Hand Deformities, Congenital | 1 | 1976 | 15 | 0.030 |
Why?
|
| Obstetrics | 1 | 2018 | 123 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2000 | 836 | 0.030 |
Why?
|
| Radius | 1 | 1976 | 31 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 1996 | 81 | 0.030 |
Why?
|
| Hemoglobins | 2 | 2008 | 193 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1008 | 0.030 |
Why?
|
| Point Mutation | 1 | 1996 | 245 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2015 | 70 | 0.030 |
Why?
|
| Bone Diseases | 1 | 2016 | 57 | 0.030 |
Why?
|
| Duodenoscopes | 1 | 2015 | 7 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 1996 | 253 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2018 | 341 | 0.030 |
Why?
|
| Polysomnography | 1 | 2015 | 151 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 111 | 0.030 |
Why?
|
| Home Nursing | 1 | 1994 | 19 | 0.030 |
Why?
|
| Back Pain | 1 | 1994 | 42 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 1994 | 45 | 0.030 |
Why?
|
| Glucuronosyltransferase | 1 | 2015 | 186 | 0.030 |
Why?
|
| Fetal Diseases | 1 | 1994 | 82 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2006 | 3240 | 0.030 |
Why?
|
| Gene Expression | 2 | 1996 | 1309 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 136 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 2013 | 10 | 0.030 |
Why?
|
| Flatfoot | 1 | 1993 | 7 | 0.030 |
Why?
|
| Cost of Illness | 1 | 1994 | 148 | 0.030 |
Why?
|
| Cementation | 1 | 1993 | 4 | 0.030 |
Why?
|
| Osteotomy | 1 | 2013 | 33 | 0.030 |
Why?
|
| Massachusetts | 1 | 1993 | 33 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 2013 | 46 | 0.030 |
Why?
|
| Index of Orthodontic Treatment Need | 1 | 2013 | 1 | 0.030 |
Why?
|
| Oral Hygiene | 1 | 2013 | 4 | 0.030 |
Why?
|
| Evidence-Based Dentistry | 1 | 2013 | 10 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 1993 | 72 | 0.030 |
Why?
|
| Spinal Diseases | 1 | 1993 | 44 | 0.030 |
Why?
|
| Hip Prosthesis | 1 | 1993 | 33 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2013 | 82 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 185 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2013 | 68 | 0.030 |
Why?
|
| Ligaments, Articular | 2 | 2011 | 38 | 0.030 |
Why?
|
| Soft Tissue Neoplasms | 2 | 1992 | 128 | 0.030 |
Why?
|
| Counseling | 1 | 1994 | 166 | 0.030 |
Why?
|
| Walking | 1 | 1993 | 93 | 0.030 |
Why?
|
| Fibroblasts | 3 | 2007 | 759 | 0.030 |
Why?
|
| Hydroxycholecalciferols | 2 | 1982 | 13 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2013 | 77 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 91 | 0.030 |
Why?
|
| Bacteremia | 1 | 2013 | 102 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 270 | 0.020 |
Why?
|
| Weight Loss | 1 | 2013 | 231 | 0.020 |
Why?
|
| Ganglionectomy | 1 | 1991 | 2 | 0.020 |
Why?
|
| Hip Dislocation | 1 | 1991 | 9 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 2449 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2011 | 36 | 0.020 |
Why?
|
| Arteriovenous Malformations | 1 | 1992 | 45 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2011 | 8 | 0.020 |
Why?
|
| Bone Wires | 1 | 2011 | 13 | 0.020 |
Why?
|
| Colonoscopes | 1 | 2011 | 13 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2007 | 1798 | 0.020 |
Why?
|
| Orthotic Devices | 1 | 2011 | 9 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 1991 | 75 | 0.020 |
Why?
|
| Nanostructures | 1 | 2012 | 79 | 0.020 |
Why?
|
| Vertebroplasty | 1 | 2011 | 8 | 0.020 |
Why?
|
| Calcitonin | 1 | 2011 | 38 | 0.020 |
Why?
|
| Fluorescence | 1 | 2011 | 103 | 0.020 |
Why?
|
| Chromatin | 1 | 2014 | 402 | 0.020 |
Why?
|
| Disease Progression | 2 | 2006 | 1463 | 0.020 |
Why?
|
| Thiophenes | 1 | 2011 | 43 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2007 | 2884 | 0.020 |
Why?
|
| Diphosphonates | 1 | 2011 | 34 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 1992 | 175 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 1853 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2011 | 44 | 0.020 |
Why?
|
| Nerve Block | 1 | 2011 | 50 | 0.020 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 88 | 0.020 |
Why?
|
| Contraindications | 1 | 2010 | 70 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 3465 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 136 | 0.020 |
Why?
|
| Diaphyses | 1 | 2009 | 7 | 0.020 |
Why?
|
| Video Recording | 1 | 2011 | 203 | 0.020 |
Why?
|
| Gastric Lavage | 2 | 1986 | 3 | 0.020 |
Why?
|
| Phlebotomy | 1 | 2009 | 22 | 0.020 |
Why?
|
| Physical Therapy Modalities | 1 | 2010 | 84 | 0.020 |
Why?
|
| Arm | 2 | 1992 | 99 | 0.020 |
Why?
|
| In Situ Hybridization | 3 | 1995 | 313 | 0.020 |
Why?
|
| Rotator Cuff Injuries | 1 | 2010 | 43 | 0.020 |
Why?
|
| Duodenal Neoplasms | 1 | 2009 | 19 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 5337 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2011 | 332 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2010 | 119 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2009 | 95 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 60 | 0.020 |
Why?
|
| Automation | 1 | 2009 | 111 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2010 | 232 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2010 | 298 | 0.020 |
Why?
|
| Polyps | 1 | 2009 | 29 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2009 | 114 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 451 | 0.020 |
Why?
|
| Curettage | 1 | 1988 | 14 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2013 | 1101 | 0.020 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2008 | 8 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 178 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1768 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 776 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 336 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 984 | 0.020 |
Why?
|
| Particle Size | 1 | 2008 | 125 | 0.020 |
Why?
|
| Administration, Oral | 2 | 1986 | 666 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2007 | 45 | 0.020 |
Why?
|
| Hemangioma | 2 | 1992 | 64 | 0.020 |
Why?
|
| Mice | 3 | 2006 | 11832 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 1705 | 0.020 |
Why?
|
| Carcinogens | 1 | 2007 | 111 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 899 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 661 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2010 | 428 | 0.020 |
Why?
|
| Hemoperfusion | 1 | 1986 | 5 | 0.020 |
Why?
|
| Thiamine | 1 | 1986 | 8 | 0.020 |
Why?
|
| Methods | 1 | 1986 | 151 | 0.020 |
Why?
|
| Snail Family Transcription Factors | 1 | 2006 | 47 | 0.020 |
Why?
|
| Antidotes | 1 | 1986 | 23 | 0.020 |
Why?
|
| Cathartics | 1 | 1986 | 27 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2006 | 84 | 0.020 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2006 | 26 | 0.020 |
Why?
|
| Medical History Taking | 1 | 1986 | 82 | 0.020 |
Why?
|
| Digestive System Neoplasms | 1 | 2006 | 21 | 0.020 |
Why?
|
| Urine | 1 | 1986 | 92 | 0.020 |
Why?
|
| Fascia | 2 | 1996 | 31 | 0.020 |
Why?
|
| Arthritis, Infectious | 1 | 1985 | 16 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 231 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 453 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2005 | 39 | 0.020 |
Why?
|
| Cadherins | 1 | 2006 | 163 | 0.020 |
Why?
|
| Celecoxib | 1 | 2005 | 31 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2007 | 170 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1986 | 503 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 222 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 1995 | 29 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 1996 | 2021 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 1048 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2005 | 150 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1985 | 160 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2009 | 555 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 642 | 0.010 |
Why?
|
| Blotting, Northern | 2 | 1996 | 258 | 0.010 |
Why?
|
| Acute Disease | 1 | 1986 | 842 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 3659 | 0.010 |
Why?
|
| Fractals | 1 | 2004 | 42 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 1983 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1986 | 497 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2004 | 125 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2006 | 395 | 0.010 |
Why?
|
| Glucose | 1 | 1986 | 629 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1986 | 337 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2006 | 238 | 0.010 |
Why?
|
| Quality of Life | 1 | 1991 | 1673 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2005 | 318 | 0.010 |
Why?
|
| Complement Activating Enzymes | 1 | 1982 | 3 | 0.010 |
Why?
|
| Complement C1q | 1 | 1982 | 11 | 0.010 |
Why?
|
| Rheumatoid Factor | 1 | 1982 | 25 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1982 | 155 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 919 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 774 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 688 | 0.010 |
Why?
|
| Osteoma, Osteoid | 1 | 1981 | 8 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1982 | 112 | 0.010 |
Why?
|
| Tibial Fractures | 1 | 1981 | 36 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1668 | 0.010 |
Why?
|
| Device Removal | 1 | 2001 | 168 | 0.010 |
Why?
|
| Vitamin D | 1 | 1981 | 269 | 0.010 |
Why?
|
| Torticollis | 1 | 1978 | 11 | 0.010 |
Why?
|
| Pain | 1 | 1981 | 399 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1977 | 64 | 0.010 |
Why?
|
| Procollagen | 1 | 1996 | 8 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 1978 | 124 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1996 | 58 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1982 | 589 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1996 | 80 | 0.010 |
Why?
|
| Orofaciodigital Syndromes | 1 | 1976 | 2 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1996 | 130 | 0.010 |
Why?
|
| Thumb | 1 | 1976 | 23 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1976 | 113 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1976 | 78 | 0.010 |
Why?
|
| Muscles | 1 | 1976 | 193 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2006 | 3397 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1995 | 17 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1995 | 49 | 0.010 |
Why?
|
| Fibromatosis, Aggressive | 1 | 1995 | 11 | 0.010 |
Why?
|
| Cell Division | 1 | 1996 | 692 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 127 | 0.010 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1994 | 5 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1976 | 386 | 0.010 |
Why?
|
| Progesterone | 1 | 1995 | 110 | 0.010 |
Why?
|
| Estrogens | 1 | 1995 | 200 | 0.010 |
Why?
|
| Intestinal Absorption | 2 | 1986 | 125 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1976 | 365 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1993 | 116 | 0.010 |
Why?
|
| Calcifediol | 2 | 1982 | 20 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1994 | 714 | 0.010 |
Why?
|
| Oncogenes | 1 | 1992 | 97 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 323 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1993 | 468 | 0.010 |
Why?
|
| Base Sequence | 1 | 1995 | 2329 | 0.010 |
Why?
|
| Bone and Bones | 2 | 1982 | 271 | 0.010 |
Why?
|
| Prevalence | 1 | 1994 | 1247 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 3024 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1992 | 394 | 0.010 |
Why?
|
| Macrophages | 1 | 1993 | 578 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1986 | 120 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1992 | 1281 | 0.000 |
Why?
|
| Kinetics | 1 | 1986 | 1534 | 0.000 |
Why?
|
| Hand Deformities, Acquired | 1 | 1982 | 5 | 0.000 |
Why?
|
| Anemia, Hypochromic | 1 | 1982 | 5 | 0.000 |
Why?
|
| 24,25-Dihydroxyvitamin D 3 | 1 | 1981 | 2 | 0.000 |
Why?
|
| Dihydroxycholecalciferols | 1 | 1981 | 10 | 0.000 |
Why?
|
| Cervical Atlas | 1 | 1978 | 3 | 0.000 |
Why?
|